General Hospital Of Imathia Monada Veria
- Address
- Asomata Street, 591 32 Veria, Greece
General Hospital Of Imathia Monada Veria - Cardiac Arrhythmia Research
General Hospital Of Imathia Monada Veria is actively engaged in cardiovascular research with a particular emphasis on cardiac arrhythmia management and innovative treatment strategies for acute cardiac rhythm disturbances. The center specializes in comparative effectiveness studies examining novel pharmacological approaches to restore normal heart rhythm.
- Cardioversion strategies for recent onset atrial fibrillation
- Combined antiarrhythmic therapy protocols
- Acute cardiac rhythm disorder management
The hospital's research program focuses on optimizing treatment protocols for patients presenting with recent onset atrial fibrillation, investigating the synergistic effects of multiple antiarrhythmic agents. Through prospective, randomized clinical trials, the center contributes valuable evidence to support clinical decision-making in acute arrhythmia management, evaluating both intravenous and oral pharmacological interventions within the critical 48-hour window of arrhythmia onset.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in General Hospital Of Imathia Monada Veria
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Intravenous Flecainide Acetate with Oral Ranolazine vs. Intravenous Flecainide Acetate in Cardioversion of Recent-Onset Atrial Fibrillation | Win Medica Pharmaceutical S.A. | Phase III | Not Recruiting | Mar 2023 | May 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Flecainide Acetate | 1 | Unknown | 2023-03-23 | 2023-03-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.